PCSK9 and homozygous familial hypercholesterolemia: Evinacumab may be of great help in lowering LDL-C levels in patients with HoFH in whom the available treatment (statins, ezetimibe, PCSK9 inhibitors) did not achieve the therapeutic goal [37].